CEPI expands global manufacturing network, reserving manufacturing capacity for more than 1 billion doses of COVID-19 vaccines – CEPI

CEPI 91d 2 tweets

CEPI has signed agreements with Biofabri (Spain) and GC Pharma (Republic of Korea) to reserve vaccine manufacturing capacity for more than 1 billion doses of COVID-19 vaccines designated by CEPI.

CEPI 91d ago

CEPI has signed agreements w/ Biofabri (Spain) & GC Pharma (Republic of Korea) to reserve vaccine manufacturing capacity for over 1 billion doses of CEPI-supported COVID-19 vaccines 🏭💉

Tedros Adhanom Ghebreyesus 91d ago

.@CEPIvaccines has reserved manufacturing capacity for 1 Billion #COVID19 vaccine doses. This will help the COVAX partnership with @who & @gavi produce & equitably deliver 2B doses of safe & effective vaccines by end-2021. #ACTogether